782 – Long-Acting Formulations of Pretomanid and Diarylquinoline TBAJ-876 for Tuberculosis Treatment
Background Tuberculosis (TB) is the leading cause of death in people with HIV. HIV is the single strongest risk factor for progression from latent TB infection to active TB disease. TB is fully curable disease, however, adherence to medication is essential for TB treatment success. Long-acting injectable (LAI) formulations with sustained drug release for months…